PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit - SensoLyte® Fluorimetric NADP/NADPH Assay Kit is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NADP/NADPH - AnaSpec.com / Eurogentec.com
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit

 

NewswireToday - /newswire/ - Fremont, CA, United States, 2012/01/19 - SensoLyte® Fluorimetric NADP/NADPH Assay Kit is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NADP/NADPH - AnaSpec.com / Eurogentec.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NADP/NADPH. NADP is converted to NADPH in an enzyme-cycling reaction. The kit contains a fluorogenic reagent, producing fluorescence when reacted with NADPH. The resulting red fluorescence can be monitored at excitation /emission= 560/590 nm, with the intensity of fluorescence produced being proportional to NADP/NADPH concentration. This assay detects as low as 1.5 nM of the analyte.

Pyridine nucleotides are involved in a number of critical catabolic and anabolic reactions in living organisms. Nicotinamide adenine dinucleotide phosphate (NADP) is a natural coenzyme present in all animal and plant organisms. Cellular NADPH is important for tolerance to ROS and maintenance of cellular redox homeostasis.1-5 The reducing power of NADPH is a required cofactor for enzymes that are prooxidant such as nitric oxide synthase and NADPH oxidase.6 Furthermore the NADP+/NADPH ratio has been found to change in the erythrocytes of subjects affected by hemolytic disorder.7, 8

In addition to the fluorimetric kit, AnaSpec also provides a convenient colorimetric kit. This kit also detects NADP and NADPH without interfering with NAD/NADH. The SensoLyte® Colorimetric NADP/NADPH Assay Kit utilizes an enzyme cycling reaction to produce a blue colored product, formazan, which can be monitored at 565 nm using a microplate reader. The intensity of the color produced is proportional to NADP/NADPH concentration.

References
1. Holmgren, A. J. Biol. Chem. 264, 13963 (1989).
2. Grant, CM. et al. Mol. Microbiol 21, 171 (1996a).
3. Muller, EG. et al. Mol. Biol.Cell 7, 1805 (1996).
4. Ng, CH. et al. Free Radic. Biol. Med. 44, 1131 (2008).
5. Temple, MD. et al. Trends Cell Biol. 15, 319 (2005).
6. Stamler, JS. et al. Science 258, 1898 (1992).
7. Kirkman, HN. et al. J. Clin. Invest. 55, 875 (1975).
8. Magnani, M. Acta Haematol. 75, 211 (1986).

For more information, please visit anaspec.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Tiffany Kao - AnaSpec.com 
510-791-9560
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)